301257.SZ Stock Analysis
30
Uncovered
SMO Clinplus Co Ltd is uncovered by Eyestock quantitative analysis.
SMO ClinPlus Co., Ltd. provides site management organization (SMO) services for clinical research and development. The company is headquartered in Shanghai, Shanghai and currently employs 3,343 full-time employees. The company went IPO on 2022-05-17. The firm mainly provides SMO services for domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The firm provides customers with services including pre-preparation planning, start-up of test sites, on-site execution and full-process management of projects. The firm operates its businesses both in the domestic market and overseas markets.